JNCE

Jounce Therapeutics, Inc. Common Stock
JNCE

Overview Fund Activity
Delisted

JNCE was delisted on the 3rd of May, 2023.

Back to rankings

100 hedge funds and large institutions have $221M invested in Jounce Therapeutics, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 30 increasing their positions, 24 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
100
Holders Change
+23
Holders Change %
+29.87%
% of All Funds
1.97%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
32
Increased
30
Reduced
24
Closed
8
Calls
$876K
Puts
$839K
Net Calls
+$37K
Net Calls Change
-$20K

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
$10.8M
2
Marshall Wace
Marshall Wace
United Kingdom
$4.13M
3
Renaissance Technologies
Renaissance Technologies
New York
$3.58M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
$5.93M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
$1.75M

Top Sellers

1
Wellington Management Group
Wellington Management Group
Massachusetts
$0
2
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
$1.53M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
$298K
4
Millennium Management
Millennium Management
New York
$561K
5
SO
STRS Ohio
Ohio
$593K
Name Holding Trade Value Shares
Change 		Shares
Change %
HSBC Holdings
101
HSBC Holdings
United Kingdom
– -$48K -14,464 Closed
JG
102
Jefferies Group
New York
– -$45K -13,557 Closed
RC
103
RBF Capital
California
– -$36K -10,924 Closed
Victory Capital Management
104
Victory Capital Management
Texas
– -$10K -2,910 Closed
QT
105
Quantamental Technologies
New York
– -$7K -1,955 Closed
IUHSA
106
Itau Unibanco Holding S.A.
Brazil
– -$2K -380 Closed
1 2 3 4
5